JOHN L ERB
CIK 1213867 · CEO and President · last filed 2025-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$128.8K
Companies
7
Total Filings
48
Lifetime Open-Market Net
-$1.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUWE | CEO and President | 743 | $1.42 | $1.1K | $0 | 6 | 2025-07-01 |
| Miromatrix Medical Inc. (MIRO) Delisted | Director | 0 | $3.39 | $0 | $50.0K | 6 | 2023-12-13 |
| Nuwellis, Inc. (CHFS) Delisted | Chairman of the Board | 11,615 | $5.28 | $61.3K | $100.0K | 5 | 2021-01-26 |
| ELMD | Director | 3,000 | $42.58 | $127.7K | $0 | 1 | 2019-12-04 |
| Nuwellis, Inc. (SSH) Delisted | CEO and President | 115,468 | — | — | $0 | 1 | 2017-04-20 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Director | 12,451 | — | — | -$1.77M | 17 | 2016-05-03 |
| SENORX INC (SENO) Delisted | Director | 10,652 | — | — | $28.5K | 6 | 2010-07-07 |
Recent Filings · Page 3 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-11-29 | — | Buy (P) | +80,000 | $17.6K | |
| 2016-05-03 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | +1,427 | -$25.1K | EDGAR |
| 2016-04-29 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | — | -$259.7K | EDGAR |
| 2016-03-17 | — | Mixed | +358,500 | $2.3K | |
| 2016-03-16 | — | Buy (P) | +16,000 | $14.5K | |
| 2015-05-26 | — | Grant (A) | +5,439 | $0 | |
| 2015-05-04 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | +1,229 | -$34.3K | EDGAR |
| 2015-02-20 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | — | -$221.7K | EDGAR |
| 2013-11-12 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | — | -$527.9K | EDGAR |
| 2013-07-29 | VASCULAR SOLUTIONS INC (VASC) Delisted | Tax (F) | −2,737 | -$44.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.